Global and United States Acute Myeloid Leukemia Treatment Market Report & Forecast 2024-2031

Report ID: 1844076 | Published Date: Oct 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Acute Myeloid Leukemia Treatment Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Acute Myeloid Leukemia Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Acute Myeloid Leukemia Treatment Market Size for the Year 2017-2028
        1.2.2 Global Acute Myeloid Leukemia Treatment Market Size for the Year 2017-2028
    1.3 Acute Myeloid Leukemia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Acute Myeloid Leukemia Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Acute Myeloid Leukemia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Acute Myeloid Leukemia Treatment Market Dynamics
        1.4.1 Acute Myeloid Leukemia Treatment Industry Trends
        1.4.2 Acute Myeloid Leukemia Treatment Market Drivers
        1.4.3 Acute Myeloid Leukemia Treatment Market Challenges
        1.4.4 Acute Myeloid Leukemia Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Acute Myeloid Leukemia Treatment by Type
    2.1 Acute Myeloid Leukemia Treatment Market Segment by Type
        2.1.1 DC Regimen
        2.1.2 AVD Regimen
        2.1.3 VCD Regimen
    2.2 Global Acute Myeloid Leukemia Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Acute Myeloid Leukemia Treatment Market Size by Type (2017-2028)
    2.4 United States Acute Myeloid Leukemia Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Acute Myeloid Leukemia Treatment Market Size by Type (2017-2028)
3 Acute Myeloid Leukemia Treatment by Application
    3.1 Acute Myeloid Leukemia Treatment Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Acute Myeloid Leukemia Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Acute Myeloid Leukemia Treatment Market Size by Application (2017-2028)
    3.4 United States Acute Myeloid Leukemia Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Acute Myeloid Leukemia Treatment Market Size by Application (2017-2028)
4 Global Acute Myeloid Leukemia Treatment Competitor Landscape by Company
    4.1 Global Acute Myeloid Leukemia Treatment Market Size by Company
        4.1.1 Top Global Acute Myeloid Leukemia Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Acute Myeloid Leukemia Treatment Revenue by Player (2017-2022)
    4.2 Global Acute Myeloid Leukemia Treatment Concentration Ratio (CR)
        4.2.1 Acute Myeloid Leukemia Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Acute Myeloid Leukemia Treatment in 2021
        4.2.3 Global Acute Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Acute Myeloid Leukemia Treatment Headquarters, Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Acute Myeloid Leukemia Treatment Headquarters and Area Served
        4.3.2 Global Acute Myeloid Leukemia Treatment Companies Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Acute Myeloid Leukemia Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Acute Myeloid Leukemia Treatment Market Size by Company
        4.5.1 Top Acute Myeloid Leukemia Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Acute Myeloid Leukemia Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Acute Myeloid Leukemia Treatment Market Size by Region
    5.1 Global Acute Myeloid Leukemia Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Acute Myeloid Leukemia Treatment Market Size by Region (2017-2028)
        5.2.1 Global Acute Myeloid Leukemia Treatment Market Size by Region: 2017-2022
        5.2.2 Global Acute Myeloid Leukemia Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Acute Myeloid Leukemia Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Ambit Biosciences Corporation
        7.1.1 Ambit Biosciences Corporation Company Details
        7.1.2 Ambit Biosciences Corporation Business Overview
        7.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Introduction
        7.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
        7.1.5 Ambit Biosciences Corporation Recent Development
    7.2 Celgene Corporation
        7.2.1 Celgene Corporation Company Details
        7.2.2 Celgene Corporation Business Overview
        7.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Introduction
        7.2.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
        7.2.5 Celgene Corporation Recent Development
    7.3 Cephalon
        7.3.1 Cephalon Company Details
        7.3.2 Cephalon Business Overview
        7.3.3 Cephalon Acute Myeloid Leukemia Treatment Introduction
        7.3.4 Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
        7.3.5 Cephalon Recent Development
    7.4 Clavis Pharma
        7.4.1 Clavis Pharma Company Details
        7.4.2 Clavis Pharma Business Overview
        7.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Introduction
        7.4.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
        7.4.5 Clavis Pharma Recent Development
    7.5 Eisai
        7.5.1 Eisai Company Details
        7.5.2 Eisai Business Overview
        7.5.3 Eisai Acute Myeloid Leukemia Treatment Introduction
        7.5.4 Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
        7.5.5 Eisai Recent Development
    7.6 Genzyme Corporation
        7.6.1 Genzyme Corporation Company Details
        7.6.2 Genzyme Corporation Business Overview
        7.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Introduction
        7.6.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
        7.6.5 Genzyme Corporation Recent Development
    7.7 Sunesis Pharmaceuticals
        7.7.1 Sunesis Pharmaceuticals Company Details
        7.7.2 Sunesis Pharmaceuticals Business Overview
        7.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Introduction
        7.7.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
        7.7.5 Sunesis Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Acute Myeloid Leukemia Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Acute Myeloid Leukemia Treatment Market Trends
    Table 3. Acute Myeloid Leukemia Treatment Market Drivers
    Table 4. Acute Myeloid Leukemia Treatment Market Challenges
    Table 5. Acute Myeloid Leukemia Treatment Market Restraints
    Table 6. Global Acute Myeloid Leukemia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Acute Myeloid Leukemia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Acute Myeloid Leukemia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Acute Myeloid Leukemia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Acute Myeloid Leukemia Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Acute Myeloid Leukemia Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Acute Myeloid Leukemia Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Acute Myeloid Leukemia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Acute Myeloid Leukemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Treatment as of 2021)
    Table 15. Top Players of Acute Myeloid Leukemia Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Acute Myeloid Leukemia Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Acute Myeloid Leukemia Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Acute Myeloid Leukemia Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Acute Myeloid Leukemia Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Acute Myeloid Leukemia Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Acute Myeloid Leukemia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Acute Myeloid Leukemia Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Acute Myeloid Leukemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Acute Myeloid Leukemia Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Acute Myeloid Leukemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Acute Myeloid Leukemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Acute Myeloid Leukemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Ambit Biosciences Corporation Company Details
    Table 31. Ambit Biosciences Corporation Business Overview
    Table 32. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product
    Table 33. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 34. Ambit Biosciences Corporation Recent Development
    Table 35. Celgene Corporation Company Details
    Table 36. Celgene Corporation Business Overview
    Table 37. Celgene Corporation Acute Myeloid Leukemia Treatment Product
    Table 38. Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 39. Celgene Corporation Recent Development
    Table 40. Cephalon Company Details
    Table 41. Cephalon Business Overview
    Table 42. Cephalon Acute Myeloid Leukemia Treatment Product
    Table 43. Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 44. Cephalon Recent Development
    Table 45. Clavis Pharma Company Details
    Table 46. Clavis Pharma Business Overview
    Table 47. Clavis Pharma Acute Myeloid Leukemia Treatment Product
    Table 48. Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 49. Clavis Pharma Recent Development
    Table 50. Eisai Company Details
    Table 51. Eisai Business Overview
    Table 52. Eisai Acute Myeloid Leukemia Treatment Product
    Table 53. Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 54. Eisai Recent Development
    Table 55. Genzyme Corporation Company Details
    Table 56. Genzyme Corporation Business Overview
    Table 57. Genzyme Corporation Acute Myeloid Leukemia Treatment Product
    Table 58. Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 59. Genzyme Corporation Recent Development
    Table 60. Sunesis Pharmaceuticals Company Details
    Table 61. Sunesis Pharmaceuticals Business Overview
    Table 62. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product
    Table 63. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million)
    Table 64. Sunesis Pharmaceuticals Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acute Myeloid Leukemia Treatment Product Picture
    Figure 2. Global Acute Myeloid Leukemia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Acute Myeloid Leukemia Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Acute Myeloid Leukemia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Acute Myeloid Leukemia Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Acute Myeloid Leukemia Treatment Market Share in Global 2017-2028
    Figure 7. Acute Myeloid Leukemia Treatment Report Years Considered
    Figure 8. Product Picture of DC Regimen
    Figure 9. Product Picture of AVD Regimen
    Figure 10. Product Picture of VCD Regimen
    Figure 11. Global Acute Myeloid Leukemia Treatment Market Share by Type in 2022 & 2028
    Figure 12. Global Acute Myeloid Leukemia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Acute Myeloid Leukemia Treatment Market Share by Type (2017-2028)
    Figure 14. United States Acute Myeloid Leukemia Treatment Market Share by Type in 2022 & 2028
    Figure 15. United States Acute Myeloid Leukemia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Acute Myeloid Leukemia Treatment Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospital
    Figure 18. Product Picture of Clinic
    Figure 19. Product Picture of Others
    Figure 20. Global Acute Myeloid Leukemia Treatment Market Share by Application in 2022 & 2028
    Figure 21. Global Acute Myeloid Leukemia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Acute Myeloid Leukemia Treatment Market Share by Application (2017-2028)
    Figure 23. United States Acute Myeloid Leukemia Treatment Market Share by Application in 2022 & 2028
    Figure 24. United States Acute Myeloid Leukemia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Acute Myeloid Leukemia Treatment Market Share by Application (2017-2028)
    Figure 26. North America Acute Myeloid Leukemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Acute Myeloid Leukemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Acute Myeloid Leukemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Acute Myeloid Leukemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2017-2022)
    Figure 55. Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2017-2022)
    Figure 56. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2017-2022)
    Figure 57. Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2017-2022)
    Figure 58. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2017-2022)
    Figure 59. Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2017-2022)
    Figure 60. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ambit Biosciences Corporation
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Frequently Asked Questions
Acute Myeloid Leukemia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Myeloid Leukemia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Myeloid Leukemia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Acute Pancreatitis

Acute Pancreatitis market is segmented by region (country), players, by Type and by Application.  ... Read More

ADHD Therapeutics

ADHD Therapeutics market is segmented by region (country), players, by Type and by Application. P ... Read More